Torrent Pharma

Torrent Pharma, the flagship Company of Torrent Group is one of the leading pharma companies in the Country. The Company was a pioneer in initiating the concept of niche marketing in India and today is ranked amongst the leaders in the therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), women's healthcare (WHC), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has a significant presence in diabetology, pain management, gynecology, oncology, and anti-infective segments.

Torrent Pharma's competitive advantage stems from its world-class manufacturing facilities, advanced R&D capabilities, extensive domestic network, and a widespread global presence in over 50 countries.

The acquisition of Elder Pharma's Indian branded business in 2013, the Dermaceutical business of Zyg Pharma in 2015, the API plant of Glochem Industries in 2016, women healthcare brands from Novartis, Unichem's Indian branded business along with its Sikkim Plant in 2017, and Curatio in 2022 strengthened Torrent Pharma's position in the Indian Pharma market.

Torrent Pharma started international acquisitions in 2005 with 90-year-old Heumann from Pfizer to enter the German market. Later on, purchased ANDA of Minocycline from Ranbaxy for the US Market in 2015.

Torrent Pharma is committed to “not just healthcare but lifecare.”